Clover Health Investments Corp (CLOV) FinancialsCLOVClover Health Investments Corp

Clover Health Investments, Corp. (CLOV) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Insurance , accounting for 99.3% of total sales, equivalent to $353.94M. Other significant revenue streams include Corporate/Other and Eliminations. Understanding this composition is critical for investors evaluating how CLOV navigates market cycles within the Managed Healthcare industry.

Evaluating the bottom line, Clover Health Investments, Corp. maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 4.21%, while the net margin is 3.77%. These profitability ratios, combined with a Return on Equity (ROE) of -5.10%, provide a clear picture of how effectively CLOV converts its operational activities into shareholder value.

In the context of the broader market, CLOV competes directly with industry leaders such as PRVA and BHF. With a market capitalization of $2.54B, it holds a significant position in the sector. When comparing efficiency, CLOV's gross margin of 100.00% stands against PRVA's 9.39% and BHF's N/A. Such benchmarking helps identify whether Clover Health Investments, Corp. is trading at a premium or discount relative to its financial performance.

Clover Health has shown a strong recovery in net income, reporting $27,334,000 in Q1 2026 and $28,001,000 in Q2 2026, compared to losses in previous quarters. The gross margin remains at 100%, indicating effective cost management and revenue generation.